Spago Nanomedical AB (SPAGO) — Strategic Asset Allocation Index
Spago Nanomedical AB (SPAGO) has a Strategic Asset Allocation Index of 0.4% as of March 2023. Strategic assets (PP&E of Skr784.00K plus long-term investments of Skr-) total Skr784.00K, measured against net assets of Skr182.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Spago Nanomedical AB Strategic Asset Allocation Index (2017–2022)
This chart shows how Spago Nanomedical AB's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of March 2023, the index stands at 0.4%, representing strategic assets of Skr784.00K against net assets of Skr182.81 Million SEK. Explore SPAGO cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Spago Nanomedical AB (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Spago Nanomedical AB from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Spago Nanomedical AB.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.4% | Skr853.00K | Skr853.00K | Skr- | Skr197.16 Million | ▼ -0.1 pp |
| 2021 | 0.6% | Skr1.07 Million | Skr1.07 Million | Skr- | Skr184.81 Million | ▼ -0.1 pp |
| 2020 | 0.7% | Skr1.08 Million | Skr1.08 Million | Skr- | Skr159.67 Million | ▲ +0.1 pp |
| 2019 | 0.6% | Skr828.00K | Skr828.00K | Skr- | Skr137.63 Million | ▼ -0.3 pp |
| 2018 | 0.9% | Skr1.14 Million | Skr1.14 Million | Skr- | Skr122.22 Million | ▼ -0.1 pp |
| 2017 | 1.0% | Skr1.12 Million | Skr1.12 Million | Skr- | Skr107.78 Million | — |